Alterations of tumour suppressor gene PPP2R1B in hepatocellular carcinoma

被引:21
作者
Chou, Huei-Chi
Chen, Chien-Hung
Lee, Hsuan-Shu
Lee, Cha-Ze
Huang, Guan-Tarn
Yang, Pei-Ming
Lee, Po-Huang
Sheu, Jin-Chuan
机构
[1] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 10016, Taiwan
[2] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Surg, Taipei 10016, Taiwan
关键词
hepatocellular carcinoma; PPP2R1B; aberrant transcript; protein phosphatase 2A;
D O I
10.1016/j.canlet.2007.01.016
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To evaluate whether the tumour suppressor gene, PPP2R1B, is involved in pathogenesis of hepatocellular carcinoma (HCC), reverse transcription-polymerase chain reaction (RT-PCR) and cDNA sequencing were performed. Eleven of 38 (29%) tumours and I of 34 (3%) corresponding non-tumour tissues showed coexpression of wild-type and aberrant mRNA. Various deletions were found in aberrant transcripts. Southern blot analysis did not show gene deletion in tumours, suggesting abnormal RNA splicing may be involved. These data suggest the possibility that aberrant transcripts of PPP2R1B might be associated with the development of HCC. (C) 2007 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:138 / 143
页数:6
相关论文
共 28 条
  • [1] Ahmadian M, 1997, CANCER RES, V57, P3664
  • [2] Baffa R, 1996, CANCER RES, V56, P268
  • [3] Genomic organization and precise physical location of protein phosphatase 2A regulatory subunit A beta isoform gene on chromosome band 11q23
    Baysal, BE
    Farr, JE
    Goss, JR
    Devlin, B
    Richard, CW
    [J]. GENE, 1998, 217 (1-2) : 107 - 116
  • [4] BEASLEY RP, 1988, CANCER, V61, P1942, DOI 10.1002/1097-0142(19880515)61:10<1942::AID-CNCR2820611003>3.0.CO
  • [5] 2-J
  • [6] Low frequency of alterations of the α (PPP2R1A) and β (PPP2R1B) isoforms of the subunit A of the serine-threonine phosphatase 2A in human neoplasms
    Calin, GA
    di Iasio, MG
    Caprini, E
    Vorechovsky, I
    Natali, PG
    Sozzi, G
    Croce, CM
    Barbanti-Brodano, G
    Russo, G
    Negrini, M
    [J]. ONCOGENE, 2000, 19 (09) : 1191 - 1195
  • [7] Absence of PPP2R1B gene alterations in primary ovarian cancers
    Campbell, IG
    Manolitsas, T
    [J]. ONCOGENE, 1999, 18 (46) : 6367 - 6369
  • [8] CHEN LC, 1994, CANCER RES, V54, P3021
  • [9] Type-2A protein phosphatase activity is required to maintain death receptor responsiveness
    Härmälä-Braskén, AS
    Mikhailov, A
    Söderström, TS
    Meinander, A
    Holmström, TH
    Damuni, Z
    Eriksson, JE
    [J]. ONCOGENE, 2003, 22 (48) : 7677 - 7686
  • [10] Hayashi S, 1997, CANCER RES, V57, P1981